4.7 Article

Domperidone Inhibits Clostridium botulinum C2 Toxin and Bordetella pertussis Toxin

期刊

TOXINS
卷 15, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/toxins15070412

关键词

AB-type protein toxin; ADP-ribosylating toxin; pertussis toxin; whooping cough; C2 toxin; membrane transport; chaperone; approved drug

向作者/读者索取更多资源

Bordetella pertussis toxin (PT) and Clostridium botulinum C2 toxin are ADP-ribosylating toxins that require cellular chaperones Hsp90 and Hsp70, cyclophilins, and FK506-binding proteins for translocation. Inhibition of chaperone activities can protect cells from PT and C2 intoxication. Domperidone, a dopamine receptor antagonist, was found to inhibit Hsp70 activity and protect cells from intoxication. Domperidone inhibits enzyme subunit translocation and reduces toxin uptake, making it a potential therapeutic agent for diseases caused by bacterial toxins that require Hsp70.
Bordetella pertussis toxin (PT) and Clostridium botulinum C2 toxin are ADP-ribosylating toxins causing severe diseases in humans and animals. They share a common translocation mechanism requiring the cellular chaperones Hsp90 and Hsp70, cyclophilins, and FK506-binding proteins to transport the toxins' enzyme subunits into the cytosol. Inhibitors of chaperone activities have been shown to reduce the amount of transported enzyme subunits into the cytosol of cells, thus protecting cells from intoxication by these toxins. Recently, domperidone, an approved dopamine receptor antagonist drug, was found to inhibit Hsp70 activity. Since Hsp70 is required for cellular toxin uptake, we hypothesized that domperidone also protects cells from intoxication with PT and C2. The inhibition of intoxication by domperidone was demonstrated by analyzing the ADP-ribosylation status of the toxins' specific substrates. Domperidone had no inhibitory effect on the receptor-binding or enzyme activity of the toxins, but it inhibited the pH-driven membrane translocation of the enzyme subunit of the C2 toxin and reduced the amount of PTS1 in cells. Taken together, our results indicate that domperidone is a potent inhibitor of PT and C2 toxins in cells and therefore might have therapeutic potential by repurposing domperidone to treat diseases caused by bacterial toxins that require Hsp70 for their cellular uptake.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据